Android app Apple app link

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57

By Yahoo! Finance   |   1 week ago
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57

Adaptive Biotechnologies recently reported strong first-quarter results, exceeding revenue expectations and reducing losses. Analysts forecast a 14% revenue increase and a decrease in losses for 2025. Price target rose to US$10.57, signaling positive valuation.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.